The active ingredient of the drug is tirzepatide from the American organization Eli Lilly. The Russian equivalent will be called "Sejaro".
Photo: ru.freepik.com
It should be noted that last year the Russian authorities issued Geropharm a compulsory license for the diabetes drug Semavik. This is an analogue of the Danish "Ozempik".
Earlier, the company also issued a certificate for Semavik Next. It will be an analogue of Vegovi, which is also produced in Denmark and used to treat obesity.
Recall that in early July, the Federal Antimonopoly Service suspended the purchase by the Ministry of Health of a generic expensive imported HIV drug. The reason was a complaint from the British manufacturer of the drug.
